NCT00744354: Vorinostat, Bortezomib, and Doxorubicin Hydrochloride Liposome in Treating Patients With Relapsed or Refractory Multiple Myeloma |
|
|
| Terminated | 1 | 32 | US | bortezomib, Velcade, pegylated liposomal doxorubicin hydrochloride, Doxil, vorinostat, Zolinza | UNC Lineberger Comprehensive Cancer Center, Merck Sharp & Dohme LLC, Millennium Pharmaceuticals, Inc., Ortho Biotech, Inc. | Multiple Myeloma and Plasma Cell Neoplasm | 12/11 | 04/15 | | |